Breaks Categories: News

ThursdayApr 25, 2024 3:13 pm

NetworkNewsBreaks – HeartBeam Inc. (NASDAQ: BEAT) Schedules Conference Call to Discuss Q1 2024 Results

HeartBeam (NASDAQ: BEAT), a cardiac technology company that has developed the first and only credit card-size 3D-vector electrocardiogram (“VECG”) platform for patient use at home, today announced that it will hold a conference call on Thursday, May 9, 2024, at 4:30 p.m. Eastern Time to discuss its results for the first quarter ended March 31, 2024. In addition, the company will provide regulatory updates, review ongoing initiatives, and detail anticipated 2024 milestones. HeartBeam CEO and Founder Branislav Vajdic, President Robert Eno and Consulting CFO Richard Brounstein will host the conference call and answer questions from attendees. A presentation will accompany…

Continue Reading

ThursdayApr 25, 2024 2:42 pm

NetworkNewsBreaks – Cybin Inc. (NYSE American: CYBN) (Cboe CA: CYBN) Announces Participation at the 27th Annual Milken Institute Global Conference

Cybin (NYSE American: CYBN) (Cboe CA: CYBN), a clinical-stage biopharmaceutical company developing new and innovative next-generation psychedelic-based treatment options, is announcing its participation at the 27th Annual Milken Institute Global Conference, set to take place May 5-8, 2024, at the Beverly Hilton in Los Angeles. According to the announcement, Doug Drysdale, Cybin CEO, will appear on a panel entitled “Collaborating for Improved Mental Health,” on May 8, 2024, at 10:00 am PDT. “The Conference provides a meaningful platform to exchange ideas with global thought leaders and share our vision for transforming the treatment paradigm for mental health. With the recent…

Continue Reading

ThursdayApr 25, 2024 1:59 pm

NetworkNewsBreaks – Kartoon Studios Inc. (NYSE American: TOON) Announces Initial Closing of $4M Registered Direct Offering

Kartoon Studios (NYSE American: TOON), a global end-to-end creator, producer, distributor, marketer and licensor of entertainment brands, recently announced the initial closing of a registered direct offering to a certain institutional investor. The announcement noted that the offering is pursuant to a securities purchase agreement, dated April 18, 2024, of up to 7,000,000 shares of the company’s common stock, par value $0.001 per share, and/or pre-funded warrants to purchase shares of common stock, of which 3,900,000 shares and 100,000 pre-funded warrants were issued and sold on April 23, 2024. An additional 3,000,000 shares and/or pre-funded warrants may be issued and…

Continue Reading

ThursdayApr 25, 2024 1:53 pm

NetworkNewsBreaks – Sustain SoCal to Explore Innovative Techno-Policy Solutions to Waste-Related Challenges at Upcoming Conference

Sustain Southern California (“Sustain SoCal”), a non-profit organization accelerating cleantech economic growth and sustainability, is announcing plans to host the Waste Stream Management and Circularity Conference. The in-person event is set to take place at the Frank R. Bowerman Landfill in Irvine, California, on Wednesday, May 15, 2024. In collaboration with Orange County Waste and Recycling, Sustain SoCal will delve into the pressing issues surrounding waste generation and circularity in the region. The conference will explore innovative techno-policy solutions aimed at addressing these challenges. “With the escalating challenges posed by waste generation, coupled with budget constraints and environmental concerns, it…

Continue Reading

ThursdayApr 25, 2024 1:39 pm

NetworkNewsBreaks – Nutriband Inc. (NASDAQ: NTRB) Engages IBN for Corporate Communications Expertise

Nutriband (NASDAQ: NTRB, NTRBW), a pharmaceutical company with a special focus on transdermal technologies, today announced that it has selected IBN, a multifaceted financial news and publishing company for private and public entities, to assist with its corporate communications initiatives. According to the announcement, Nutriband’s AVERSA(TM) technology can be incorporated into any transdermal patch and includes aversive agents to prevent abuse, diversion, misuse and accidental exposure to drugs with abuse potential, specifically opioids. The company’s business model is to apply its transdermal technology to existing FDA-approved drugs with the aim of improving safety, efficacy and patient comfort while qualifying for…

Continue Reading

ThursdayApr 25, 2024 1:02 pm

NetworkNewsBreaks – Golden Triangle Ventures Inc. (GTVH), Subsidiary Establish Four-Pillar Business Model to Ensure Successful Development of Destino Ranch

Golden Triangle Ventures (OTC: GTVH), a multifaceted consulting company, and its wholly owned subsidiary, Lavish Entertainment (or “Lavish”), have developed a comprehensive four-pillar business model. According to the announcement, the company intends for this key business component to be a critical component moving forward as Lavish Entertainment focuses on creating an industry-leading entertainment business. Specifically, the business model will be used as the company’s flagship project, Destino Ranch, is being developed. The new business model includes four essential key foundational elements: logistics, staffing, equipment and production. The company noted that these specific pillars were carefully identified and organized to complement…

Continue Reading

ThursdayApr 25, 2024 12:50 pm

NetworkNewsBreaks – FSD Pharma Inc. (NASDAQ: HUGE) (CSE: HUGE) (FRA:0K9A) Announces Celly Nu, Six+One Collaboration to Launch unbuzzd(TM)

FSD Pharma (NASDAQ: HUGE) (CSE: HUGE) (FRA:0K9A) today provided an update by way of a news release issued by Celly Nutrition Corp. (“Celly Nu”), and its launch of unbuzzd(TM), an innovative beverage product scientifically formulated from a proprietary blend of vitamins, minerals and botanical extracts designed to support the body’s natural processes for metabolizing alcohol and promoting alertness. Celly Nu has entered a strategic partnership with Six+One, a purpose-driven branding, advertising, and production agency based in New York City. Under the partnership, Six+One will significantly enhance the presence of the premier dietary supplement, unbuzzd, in preparation of the launch in…

Continue Reading

WednesdayApr 24, 2024 3:46 pm

NetworkNewsBreaks – Torr Metals Inc. (TSX.V: TMET) Announces Promising Preliminary Results at Kolos

Torr Metals Inc. (TSX.V: TMET) today reported preliminary results that have identified near-surface high priority geophysical resistivity anomalies extending up to >1.5 kilometers (“km”) depth that are coincident with highly anomalous copper (“Cu”), gold (“Au”), and molybdenum (“Mo”) mineralization at-surface. According to the announcement, these compelling exploration drill targets were identified using a newly completed 3D resistivity inversion voxel model, derived from the ZTEM geophysical survey completed over the entirety of the 100% owned ~140 km 2 Kolos Copper-Gold Project in late 2023. “The strong correlation between highly anomalous resistivity areas and known surface copper-gold and copper-molybdenum mineralization is incredibly…

Continue Reading

WednesdayApr 24, 2024 3:20 pm

NetworkNewsBreaks – Aston Bay Holdings Ltd. (TSX.V: BAY) (OTCQB: ATBHF) Announces Strategic Agreement and Advisory Board Appointment

Aston Bay (TSX.V: BAY) (OTCQB: ATBHF) today announced that on April 23, 2024, it entered into a definitive agreement with Emerald Geological Services (“EGS”) pursuant to which it has been granted an option to acquire an undivided 80% beneficial interest in a property owned by EGS in Nunavut, Canada. In addition, the company announced the appointment of Dr. Elizabeth Turner to its technical advisory board. “We are pleased to sign the definitive agreement for the Epworth Property,” said Thomas Ullrich, CEO of Aston Bay, “and we are very excited to have Dr. Elizabeth Turner join our technical advisory board. Dr.…

Continue Reading

WednesdayApr 24, 2024 2:54 pm

NetworkNewsBreaks – Nutriband Inc. (NASDAQ: NTRB) Closes $8.4M Private Placement

  Nutriband (NASDAQ: NTRB, NTRBW), a company engaged in the development of prescription transdermal pharmaceutical products, today announced that it has closed an $8.4 million private placement to fund the commercial development program for its lead product, AVERSA(TM) Fentanyl. AVERSA Fentanyl has the potential to be the world’s first abuse-deterrent opioid patch designed to deter the abuse and misuse and reduce the risk of accidental exposure of transdermal fentanyl patches. Nutriband is working with its partner Kindeva Drug Delivery, a leading global contract development and manufacturing organization, to develop the commercial scale manufacturing process for the final product, which will…

Continue Reading